News und Analysen

0

DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care published form 20-F for the fiscal year 2021

0

DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care veröffentlicht Form 20-F für das Geschäftsjahr 2021

0

DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care sets climate targets: Climate neutrality by 2040, CO2 emissions to fall 50% by 2030

0

DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care setzt sich Klimaziele: Klimaneutralität bis 2040, Halbierung der CO2-Emissionen bis 2030

0

DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care erfüllt Prognose und strebt für 2022 Rückkehr zu Gewinnwachstum an

0

DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care delivers on 2021 guidance, targets return to earnings growth in 2022

0

DGAP-HV: Carl Zeiss Meditec AG: Bekanntmachung der Einberufung zur Hauptversammlung am 30.03.2022 in Jena mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

0

DGAP-News: Carl Zeiss Meditec erzielt weiteres Wachstum im ersten Quartal 2021/22

0

DGAP-News: Carl Zeiss Meditec achieves further growth in first quarter of 2021/22

0

DGAP-News: Carl Zeiss Meditec erzielt Rekordumsatz im Geschäftsjahr 2020/21

0

DGAP-News: Record revenue for Carl Zeiss Meditec in fiscal year 2020/21

0

DGAP-News: Fresenius Medical Care AG & Co. KGaA passt Besetzung des Vorstands an neues Betriebsmodell an

0

DGAP-News: Fresenius Medical Care AG & Co. KGaA announces changes to Management Board, reflecting the transformation to the company's new operating model

0

3 companies that more than doubled analyst EPS estimates

Earnings season is well underway, and the winner-and-loser separation continues to grow. Of the companies that beat consensus analyst estimates, even fewer go well beyond and exceed analyst

0

Merck, the Dow's hottest stock, gets set to report Q4 financials

Dow Jones Industrial Average (DJIA) stalwart Merck & Co., Inc. (NYSE:MRK) has momentum on its side heading into its February 1st earnings report.

Shares of the large cap pharmaceutical company

0

Are defensive sectors ready to outshine growth in 2024?

Defensive sectors are off to a better start to the new year than growth stocks, which dominated in 2023.

The Health Care Select Sector SPDR Fund (NYSEARCA: XLV), which has both growth and

0

PetVivo Sales Spryng Higher on Injectable OA Relief for Pets

Developmental biomedical device company PetVivo Holdings Inc. (OTCMKTS: PETV) makes pet medical devices and therapeutics. What kind of medical devices would pets need? Pacemakers? Artificial hearts

0

Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market

Big pharmaceutical stocks, including Novartis AG (NYSE: NVS), Eli Lilly & Co. (NYSE: LLY), Merck & Co. (NYSE: MRK), and Novo Nordisk A/S (NYSE: NVO) have been outperforming the broader market

0

Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding

Can-Fite BioPharma Ltd. (NYSEAMERICAN: CANF) is an Israel-based biotechnology firm that develops small-molecule therapeutic treatments for cancers, inflammatory diseases and sexual dysfunction. It